1.
Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
Shukla Dhananjay, Vidhya Nagasubramaniam, Prasad Noela M, Mahalakshmi Rajendran, Kolluru Chandarmohan, Krishnadas Ramaswami
Am J OphthalmolSep 200724 citationsCase Series
This study found younger patients (≤45) receiving intravitreal triamcinolone experienced more frequent IOP elevation, highlighting the need for age-specific monitoring.